Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Pti-428
2. 1953130-87-4
3. Nesolicitor
4. Nesolicaftor [usan]
5. T2u4za62u4
6. Nesolicaftor (usan)
7. N-[3-[5-[(1r)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide
8. 5-isoxazolecarboxamide, N-(trans-3-(5-((1r)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenyl-
9. N-(trans-3-(5-((1r)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenyl-5-isoxazolecarboxamide
10. N-(trans-3-(5-((r)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide
11. Nesolicaftor [inn]
12. Unii-t2u4za62u4
13. Nesolicaftor [who-dd]
14. Chembl4297479
15. Schembl17874059
16. Schembl17874060
17. Schembl17883798
18. Schembl17883826
19. Glxc-25543
20. Pti-428(pti428)
21. Ex-a3723
22. S6911
23. Who 11277
24. Db15239
25. Hy-111680
26. Cs-0090368
27. D11682
28. D87157
| Molecular Weight | 354.4 g/mol |
|---|---|
| Molecular Formula | C18H18N4O4 |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 354.13280507 g/mol |
| Monoisotopic Mass | 354.13280507 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 496 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Nesolicaftor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nesolicaftor, including repackagers and relabelers. The FDA regulates Nesolicaftor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nesolicaftor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nesolicaftor supplier is an individual or a company that provides Nesolicaftor active pharmaceutical ingredient (API) or Nesolicaftor finished formulations upon request. The Nesolicaftor suppliers may include Nesolicaftor API manufacturers, exporters, distributors and traders.
Nesolicaftor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nesolicaftor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nesolicaftor GMP manufacturer or Nesolicaftor GMP API supplier for your needs.
A Nesolicaftor CoA (Certificate of Analysis) is a formal document that attests to Nesolicaftor's compliance with Nesolicaftor specifications and serves as a tool for batch-level quality control.
Nesolicaftor CoA mostly includes findings from lab analyses of a specific batch. For each Nesolicaftor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nesolicaftor may be tested according to a variety of international standards, such as European Pharmacopoeia (Nesolicaftor EP), Nesolicaftor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nesolicaftor USP).
LOOKING FOR A SUPPLIER?
